Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016

Date
2017
Author
Robson, Joanna C.
Merkel, Peter A.
Milman, Nataliya
Tomasson, Gunnar
Direskeneli, Haner
Sreih, Antoine G.
Alibaz-Oner, Fatma
Kermani, Tanaz A.
Aydin, Sibel Z.
Cronholm, Peter F.
Davis, Trocon
Easley, Ebony
Gül, Ahmet
Mahr, Alfred
McAlear, Carol A.
Metadata
Show full item record
Abstract
Objective. Among the challenges in conducting clinical trials in large-vessel vasculitis (LVV), including both giant cell arteritis (GCA) and Takayasu arteritis (TA), is the lack of standardized and meaningful outcome measures. The Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group initiated an international effort to develop and validate data-driven outcome tools for clinical investigation in LVV.
URI
http://hdl.handle.net/20.500.12627/11324
https://doi.org/10.3899/jrheum.161467
Collections